The company can now initiate its phase 1/2 CLARITY trial activities for its lead in vivo genome-editing program GEB-101 for TGFBI corneal dystrophy. NCX 470 is Nicox’s lead dual-mechanism bimatoprost ...
Camille Kitt and her Identical twin sister Kennerly Kitt are are widely known as the Harp Twins and have achieved extraordinary success by taking Electric Harps and Concert Grand Harps to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results